维普中文期刊产品整合服务

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases

查看全文 作　　者：Liping [1]Liu;Weiqi [1]Chen;Hongyu [1]Zhou;Wanying [1]Duan;Shujuan [2]Li;Xiaochuan [1]Huo;Weihai [3]Xu;Li'an [4]Huang;Huaguang [1]Zheng;Jingyi [1]Liu;Hui [2]Liu;Yufei [1]Wei;Jie [1]Xu;Yongjun [1]Wang 高影响力作者 机构地区：[1]Department of Neurology,Beijing Tiantan Hospital,Capital Medical University,Beijing,China;[2]Department of Neurology,Beijing Chaoyang Hospital,Capital Medical University,Beijing,China;[3]Department of Neurology,Peking Union Medical College Hospital,Beijing,China;[4]Department of Neurology,Guangzhou Overseas Chinese Hospital,The First Affiliated Hospital of JINAN University,Guangzhou,China高影响力机构 出　　处：《Stroke & Vascular Neurology》索引2020年第5卷第2期,共18页高影响力期刊 摘　　要：Aim Stroke is the leading cause of disability and death in China.Ischaemic stroke accounts for about 60%-80%of all strokes.It is of considerable significance to carry out multidimensional management of ischaemic cerebrovascular diseases.This evidence-based guideline aims to provide the latest detailed and comprehensive recommendations on the diagnosis,treatment and secondary prevention of ischaemic cerebrovascular diseases.Methods We had performed comprehensive searches of MEDLINE(via PubMed)(before 30 June 2019),and integrated the relevant information into charts and distributed to the writing group.Writing group members discussed and determined the recommendations through teleconference.We used the level of evidence grading algorithm of Chinese Stroke Association to grade each recommendation.The draft was reviewed by the Guideline Writing Committee of Chinese Stroke Association Stroke and finalised.This guideline is fully updated every 3 years.results This evidence-based guideline is based on the treatment,care and prevention of ischaemic cerebrovascular diseases,which emphasises on pathogenesis evaluation,intravenous thrombolysis,endovascular therapy,antiplatelet therapy,prevention and treatment of complications,and risk factor management.Conclusions This updated guideline presents a framework for the management of ischaemic cerebrovascular diseases.Timely first-aid measures,professional care in the acute stage,and proactive secondary prevention will be helpful to patients. 关 键 词：prevention diagnosis treatment
相关文献

参考文献(25)

引证文献(88)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费